Investigation on critical structural motifs of ligands for triggering glucocorticoid receptor nuclear migration through molecular docking simulations

References

• Barker, M., Clackers, M., Demaine, D. A., Humphreys, D., Johnston, M. J., Jones, H. T., … Shanahan, S. E. (2005). Design and synthesis of new nonsteroidal glucocorticoid modulators through application of an “agreement docking” method. Journal of Medicinal Chemistry, 48, 4507–4510.10.1021/jm050345y
   PubMed Web of Science ®Google Scholar
• Biggadike, K., Bledsoe, R. K., Coe, D. M., Cooper, T. W., House, D., Iannone, M. A., … Shipley, T. J. (2009). Design and X-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor. Proceedings of the National Academy of Sciences, 106, 18114–18119.10.1073/pnas.0909125106
   PubMed Web of Science ®Google Scholar
• Biggadike, K., Bledsoe, R. K., Hassell, A. M., Kirk, B. E., McLay, I. M., Shewchuk, L. M., & Stewart, E. L. (2008). X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor−ligand binding domain. Journal of Medicinal Chemistry, 51, 3349–3352.10.1021/jm800279t
   PubMed Web of Science ®Google Scholar
• Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., … Willson, T. M. (2002). Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell, 110, 93–105.10.1016/S0092-8674(02)00817-6
   PubMed Web of Science ®Google Scholar
• Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., & Karplus, M. (1983). CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. Journal of Computational Chemistry, 4, 187–217.10.1002/(ISSN)1096-987X
   Web of Science ®Google Scholar
• Buchwald, P. (2008). Glucocorticoid receptor binding: A biphasic dependence on molecular size as revealed by the bilinear LinBiExp model. Steroids, 73, 193–208.10.1016/j.steroids.2007.10.001
   PubMed Web of Science ®Google Scholar
• Carson, M. W., Luz, J. G., Suen, C., Montrose, C., Zink, R., Ruan, X., … Kohlman, D. T. (2014). Glucocorticoid receptor modulators informed by crystallography lead to a new rationale for receptor selectivity, function, and implications for structure-based design. Journal of Medicinal Chemistry, 57, 849–860.10.1021/jm401616g
   PubMed Web of Science ®Google Scholar
• Cato, B., Andrew, C., Schacke, H., Sterry, W., & Asadullah, K. (2004). The glucocorticoid receptor as target for classic and novel anti-inflammatory therapy. Current Drug Targets-Inflammation & Allergy, 3, 347–353.
   PubMedGoogle Scholar
• Cavet, M. E., Harrington, K. L., Ward, K. W., & Zhang, J.-Z. (2010). Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells. Molecular vision, 16, 1791.
   PubMed Web of Science ®Google Scholar
• Chapman, K. E., Coutinho, A. E., Gray, M., Gilmour, J. S., Savill, J. S., & Seckl, J. R. (2009). The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in the inflammatory response. Molecular and Cellular Endocrinology, 301, 123–131.10.1016/j.mce.2008.09.031
   PubMed Web of Science ®Google Scholar
• Chen, Y. C., Liu, Y. L., Li, F. Y., Chang, C. I., Wang, S. Y., Lee, K. Y., … Tzen, J. T. C. (2011). Antcin A, a steroid-like compound from Antrodia camphorata, exerts anti-inflammatory effect via mimicking glucocorticoids. Acta Pharmacologica Sinica, 32(7), 904–911.10.1038/aps.2011.36
   PubMed Web of Science ®Google Scholar
• Clark, A. R. & Belvisi, M. G. (2012). Maps and legends: The quest for dissociated ligands of the glucocorticoid receptor. Pharmacology & Therapeutics, 134, 54–67.
   PubMed Web of Science ®Google Scholar
• De Bosscher, K., & Haegeman, G. (2009). Minireview: Latest perspectives on antiinflammatory actions of glucocorticoids. Molecular Endocrinology, 23, 281–291.10.1210/me.2008-0283
   PubMed Web of Science ®Google Scholar
• De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003). The interplay between the glucocorticoid receptor and nuclear factor-κB or activator protein-1: Molecular mechanisms for gene repression. Endocrine Reviews, 24, 488–522.10.1210/er.2002-0006
   PubMed Web of Science ®Google Scholar
• Dezitter, X., Fagart, J., Taront, S., Fay, M., Masselot, B., Hétuin, D., … Idziorek, T. (2014). A structural explanation of the effects of dissociated glucocorticoids on glucocorticoid receptor transactivation. Molecular Pharmacology, 85, 226–236.
   PubMed Web of Science ®Google Scholar
• Edman, K., Ahlgren, R., Bengtsson, M., Bladh, H., Bäckström, S., Dahmén, J., … Jerre, A. (2014). The discovery of potent and selective non-steroidal glucocorticoid receptor modulators, suitable for inhalation. Bioorganic & Medicinal Chemistry Letters, 24, 2571–2577.
   PubMed Web of Science ®Google Scholar
• Evans, R. (1989). Molecular characterization of the glucocorticoid receptor. Recent Progress in Hormone Research, 45, 1–27.
   PubMedGoogle Scholar
• Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., … Bornstein, S. R. (2002). Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. The FASEB Journal, 16, 61–71.10.1096/fj.01-0245com
   PubMed Web of Science ®Google Scholar
• Halgren, T. A. (1996). Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions. Journal of Computational Chemistry, 17, 520–552.10.1002/(SICI)1096-987X(199604)17:5/6<>1.0.CO;2-C
   Web of Science ®Google Scholar
• Hammer, S., Spika, I., Sippl, W., Jessen, G., Kleuser, B., Höltje, H.-D., & Schäfer-Korting, M. (2003). Glucocorticoid receptor interactions with glucocorticoids: Evaluation by molecular modeling and functional analysis of glucocorticoid receptor mutants. Steroids, 68, 329–339.10.1016/S0039-128X(03)00030-8
   PubMed Web of Science ®Google Scholar
• He, Y., Yi, W., Suino-Powell, K., Zhou, X. E., Tolbert, W. D., Tang, X., … Hou, L. (2014). Structures and mechanism for the design of highly potent glucocorticoids. Cell Research, 24, 713–726.10.1038/cr.2014.52
   PubMed Web of Science ®Google Scholar
• Heitzer, M. D., Wolf, I. M., Sanchez, E. R., Witchel, S. F., & DeFranco, D. B. (2007). Glucocorticoid receptor physiology. Reviews in endocrine and metabolic disorders, 8, 321–330.10.1007/s11154-007-9059-8
   PubMed Web of Science ®Google Scholar
• Hirschmann, R. (1992). The cortisone era: Aspects of its impact. Some contributions of the Merck Laboratories. Steroids, 57, 579–592.10.1016/0039-128X(92)90012-X
   PubMed Web of Science ®Google Scholar
• Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., … Evans, R. M. (1984). Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature, 318, 635–641.
   Web of Science ®Google Scholar
• Kassel, O., & Herrlich, P. (2007). Crosstalk between the glucocorticoid receptor and other transcription factors: Molecular aspects. Molecular and Cellular Endocrinology, 275, 13–29.10.1016/j.mce.2007.07.003
   PubMed Web of Science ®Google Scholar
• Kauppi, B., Jakob, C., Färnegårdh, M., Yang, J., Ahola, H., Alarcon, M., … Muchmore, S. (2003). The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. Journal of Biological Chemistry, 278, 22748–22754.10.1074/jbc.M212711200
   PubMed Web of Science ®Google Scholar
• Krammer, A., Kirchhoff, P. D., Jiang, X., Venkatachalam, C., & Waldman, M. (2005). LigScore: A novel scoring function for predicting binding affinities. Journal of Molecular Graphics and Modelling, 23, 395–407.10.1016/j.jmgm.2004.11.007
   PubMed Web of Science ®Google Scholar
• Kumar, R., & Thompson, E. B. (1999). The structure of the nuclear hormone receptors. Steroids, 64, 310–319.10.1016/S0039-128X(99)00014-8
   PubMed Web of Science ®Google Scholar
• Lewis-Tuffin, L. J., Jewell, C. M., Bienstock, R. J., Collins, J. B., & Cidlowski, J. A. (2007). Human glucocorticoid receptor β binds RU-486 and is transcriptionally active. Molecular and Cellular Biology, 27, 2266–2282.10.1128/MCB.01439-06
   PubMed Web of Science ®Google Scholar
• Li, X. T., Wong, J. M., Tsai, S. Y., Tsai, M. J., & O'Malley, B. W. (2003). Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Molecular and Cellular Biology, 23, 3763–3773.10.1128/MCB.23.11.3763-3773.2003
   PubMed Web of Science ®Google Scholar
• Lifson, S., & Warshel, A. (1968). Consistent force field for calculations of conformations, vibrational spectra, and enthalpies of cycloalkane and n-alkane molecules. The Journal of Chemical Physics, 49, 5116–5129.10.1063/1.1670007
   Web of Science ®Google Scholar
• Lu, N. Z., & Cidlowski, J. A. (2005). Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Molecular Cell, 18, 331–342.10.1016/j.molcel.2005.03.025
   PubMed Web of Science ®Google Scholar
• Lu, N. Z., Collins, J. B., Grissom, S. F., & Cidlowski, J. A. (2007). Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor. Molecular and Cellular Biology, 27, 7143–7160.10.1128/MCB.00253-07
   PubMed Web of Science ®Google Scholar
• Madauss, K. P., Bledsoe, R. K., Mclay, I., Stewart, E. L., Uings, I. J., Weingarten, G., & Williams, S. P. (2008). The first X-ray crystal structure of the glucocorticoid receptor bound to a non-steroidal agonist. Bioorganic & Medicinal Chemistry Letters, 18, 6097–6099.
   PubMed Web of Science ®Google Scholar
• Morishima, Y., Kanelakis, K. C., Murphy, P. J. M., Lowe, E. R., Jenkins, G. J., Osawa, Y., … Pratt, W. B. (2003). The hsp90 cochaperone p23 is the limiting component of the multiprotein hsp90/hsp70-based chaperone system in vivo where it acts to stabilize the client protein·hsp90 complex. Journal of Biological Chemistry, 278, 48754–48763.10.1074/jbc.M309814200
   PubMed Web of Science ®Google Scholar
• Newton, R. (2000). Molecular mechanisms of glucocorticoid action: what is important? Thorax, 55, 603–613.10.1136/thorax.55.7.603
   PubMed Web of Science ®Google Scholar
• Onnis, V., Kinsella, G. K., Carta, G., Fayne, D., & Lloyd, D. G. (2009). Rational ligand-based virtual screening and structure-activity relationship studies in the ligand-binding domain of the glucocorticoid receptor-α. Future Medicinal Chemistry, 1, 483–499.10.4155/fmc.09.39
   PubMed Web of Science ®Google Scholar
• Onnis, V., Kinsella, G. K., Carta, G., Jagoe, W. N., Price, T., Williams, D. C., … Lloyd, D. G. (2010). Virtual screening for the identification of novel nonsteroidal glucocorticoid modulators. Journal of Medicinal Chemistry, 53, 3065–3074.10.1021/jm901452y
   PubMed Web of Science ®Google Scholar
• Patocka, J. (1998). Anti-inflammatory triterpenoids from mysterious mushroom Ganoderma lucidum and their potential possibility in modern medicine. Acta medica (Hradec Kralove)/Universitas Carolina, Facultas Medica Hradec Kralove, 42, 123–125.
   Google Scholar
• Pratt, W., Morishima, Y., Murphy, M., & Harrell, M. (2006). Chaperoning of glucocorticoid receptors. In M. Gaestel (Ed.), Molecular Chaperones in Health and Disease (pp. 111–138). Berlin: Springer.
   Google Scholar
• Presman, D. M., Alvarez, L. D., Levi, V., Eduardo, S., Digman, M. A., Martí, M. A., … Pecci, A. (2010). Insights on glucocorticoid receptor activity modulation through the binding of rigid steroids. PLoS ONE, 5, e13279.10.1371/journal.pone.0013279
   Google Scholar
• Ray, N. C., Clark, R. D., Clark, D. E., Williams, K., Hickin, H., Crackett, P. H., … Devos, R. (2007). Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators. Bioorganic & Medicinal Chemistry Letters, 17, 4901–4905.
   PubMed Web of Science ®Google Scholar
• Ren, R., Oakley, R. H., Cruz-Topete, D., & Cidlowski, J. A. (2012). Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis. Endocrinology, 153, 5346–5360.10.1210/en.2012-1563
   PubMed Web of Science ®Google Scholar
• Robinson, R. C., & Robinson, H. M., Jr. (1956). Topical treatment of dermatoses with steroids. Southern Medical Journal, 49, 260–266.10.1097/00007611-195603000-00011
   PubMedGoogle Scholar
• Sai, S., Esteves, C. L., Kelly, V., Michailidou, Z., Anderson, K., Coll, A. P., … Chapman, K. E. (2008). Glucocorticoid regulation of the promoter of 11β-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-β. Molecular Endocrinology, 22, 2049–2060.10.1210/me.2007-0489
   PubMed Web of Science ®Google Scholar
• Schäcke, H., Döcke, W. D., & Asadullah, K. (2002). Mechanisms involved in the side effects of glucocorticoids. Pharmacology & Therapeutics, 96, 23–43.
   PubMed Web of Science ®Google Scholar
• Schäcke, H., Schottelius, A., Döcke, W. D., Strehlke, P., Jaroch, S., Schmees, N., … Asadullah, K. (2004). Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proceedings of the National Academy of Sciences, 101, 227–232.10.1073/pnas.0300372101
   PubMed Web of Science ®Google Scholar
• Schoch, G. A., D'Arcy, B., Stihle, M., Burger, D., Bär, D., Benz, J., … Ruf, A. (2010). Molecular switch in the glucocorticoid receptor: Active and passive antagonist conformations. Journal of Molecular Biology, 395, 568–577.10.1016/j.jmb.2009.11.011
   PubMed Web of Science ®Google Scholar
• Spreafico, M., Ernst, B., Lill, M. A., Smiesko, M., & Vedani, A. (2009). Mixed-model QSAR at the glucocorticoid receptor: Predicting the binding mode and affinity of psychotropic drugs. ChemMedChem, 4, 100–109.10.1002/cmdc.v4:1
   PubMed Web of Science ®Google Scholar
• Stahn, C., Löwenberg, M., Hommes, D. W., & Buttgereit, F. (2007). Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Molecular and Cellular Endocrinology, 275, 71–78.10.1016/j.mce.2007.05.019
   PubMed Web of Science ®Google Scholar
• Suino-Powell, K., Xu, Y., Zhang, C., Tao, Y.-G., Tolbert, W. D., Simons, S. S., & Xu, H. E. (2008). Doubling the size of the glucocorticoid receptor ligand binding pocket by deacylcortivazol. Molecular and Cellular Biology, 28, 1915–1923.10.1128/MCB.01541-07
   PubMed Web of Science ®Google Scholar
• Tuckermann, J. P., Kleiman, A., McPherson, K. G., & Reichardt, H. M. (2005). Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Critical Reviews in Clinical Laboratory Sciences, 42, 71–104.10.1080/10408360590888983
   PubMed Web of Science ®Google Scholar
• Wang, H., Aslanian, R., & Madison, V. S. (2008). Induced-fit docking of mometasone furoate and further evidence for glucocorticoid receptor 17α pocket flexibility. Journal of Molecular Graphics and Modelling, 27, 512–521.10.1016/j.jmgm.2008.09.002
   PubMed Web of Science ®Google Scholar
• Wu, G., Robertson, D. H., Brooks, C. L., & Vieth, M. (2003). Detailed analysis of grid-based molecular docking: A case study of CDOCKER – A CHARMm-based MD docking algorithm. Journal of Computational Chemistry, 24, 1549–1562.10.1002/(ISSN)1096-987X
   PubMed Web of Science ®Google Scholar
• Xu, Y., Zhang, T., & Chen, M. (2009). Combining 3D-QSAR, docking, molecular dynamics and MM/PBSA methods to predict binding modes for nonsteroidal selective modulator to glucocorticoid receptor. Bioorganic & Medicinal Chemistry Letters, 19, 393–396.
   PubMed Web of Science ®Google Scholar
• Zhou, J., & Cidlowski, J. A. (2005). The human glucocorticoid receptor: One gene, multiple proteins and diverse responses. Steroids, 70, 407–417.10.1016/j.steroids.2005.02.006
   PubMed Web of Science ®Google Scholar